You are here

MEDi EDDiE

MEDi EDDiE is a scalable, customizable digital health management solution driving improvements of 10%-15% in prescription adherence.

Details

Founded: 2009
Employees: 1
Follow:
Quick Pitch:

Overview

MEDi EDDiE provides a unique mix of content and delivery methodology to healthcare payers to dramatically improve prescription drug adherence. Focused on generic medications and chronic conditions, our digital solutions include video production that leverages research, design, and technology to create simple, powerful healthcare tools that reduce costs and improve patient health in $300 billion industry segment.

Management

Co-Founder

Chris Kissel

Chris Kissel is the Co-Founder of MEDi EDDiE, Inc. a digital health management company focused on prescription drug adherence and patient health engagement. Prior to MEDi EDDiE, Mr. Kissel worked in healthcare communications for Omnicom Group. Mr. Kissel earned a BA in Sociology and Anthropology from the University of Wisconsin, an MA from Minnesota State University, and an MBA from Villanova University

Co-Founder

Bob DiBetta

Accomplished senior-level executive and entrepreneur with 20-years experience leading turnarounds, start-ups, reorganizations and expansions of operations in both small and large organizations. Creative thinker known for reorganizing inefficient operations and consistently delivering improved revenues and operating margins. Mr. DIBetta earned an MBA from Villanova University.

Partner

David St.Clair

David St.Clair advises entrepreneurs and is an angel investor. He founded MEDecision in 1988 and served as the chairman of the board and chief executive officer until early 2011. From 1985 until 1988, Mr. St.Clair served as the vice president of GMIS, Inc., which was subsequently acquired by McKesson Corporation. Mr. St.Clair received a BAS in Engineering from the University of Pennsylvania, and an MBA from Harvard Business School.

Advisory Board

Steve Andriole, Ph.D.

Steve Andriole is a business technology veteran who has developed a perspective on the optimization of computing and communications technology based on experience from government, industry, academia and the venture capital business. He has served as Chief Technology Officer and Senior Vice President for Technology Strategy at CIGNA Corporation and Safeguard Scientifics, Inc. Dr. Andriole received his PhD from the University of Maryland

Advisory Board

Jeffrey P. Libson, Esq.

Jeffrey Libson is the head of the life sciences practice at Pepper Hamilton LLP. Mr. Libson’s practice is devoted primarily to the areas of securities law, venture financing, mergers and acquisitions, corporate governance and the commercialization, licensing and acquisition of intellectual property. Mr. Libson received a BA from Oberlin College and a JD from Duke University School of Law

Jobs

Know of jobs at this company? List them!

Submit a new job now